While small-rely MBL almost never progresses to CLL, substantial-count MBL progresses to CLL demanding therapy at a level of 1% to 2% per annum. Superior-depend MBL is distinguished from Rai 0 CLL depending on whether or not the B-cell rely is earlier mentioned or beneath 5 × 109/L. While pers